[Federal Register: August 2, 2002 (Volume 67, Number 149)]
[Notices]               
[Page 50442]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr02au02-64]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 02175]

 
Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Applied Research on Antimicrobial Resistance : 
Validation of National Committee for Clinical Laboratory Standards 
Breakpoints for Human Pathogens of Public Health Importance

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Applied Research on Antimicrobial 
Resistance (AR): Validation of National Committee for Clinical 
Laboratory Standards (NCCLS) Breakpoints for Human Pathogens of 
Public Health Importance, PA 02175
    Times And Date: 8:30 a.m.-9 a.m., August 22, 2002 (Open); 9:15 
a.m.-12:00 p.m., August 22, 2002 (Closed).
    Place: Atlanta Airport Hilton, 1031 Virginia Avenue, Atlanta, GA 
30354.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
PA 02175.
    Contact Person for More Information: Marsha A. Jones, Health 
Scientist, National Center for Infectious Diseases, CDC, 1600 
Clifton Road, NE, MS C-12, Atlanta, Georgia 30333, 404-639-2603, e-
mail: maj4@cdc.gov.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: July 29, 2002.
John Burckhardt,
Acting Director, Management Analysis and Services Office.
[FR Doc. 02-19511 Filed 8-1-02; 8:45 am]
BILLING CODE 4163-18-P